CI
Cigna Corporation · Healthcare · Medical - Healthcare Plans
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -1.4% · netto nieuwe posities -3.7% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 177 | 0 | 197.60M | $54.50B | +4 | −5 |
| Q1 2026 | 181 | +2 | 199.25M | $53.08B | +3 | −2 |
| Q4 2025 | 178 | +1 | 211.33M | $58.16B | +2 | n/a |
| Q3 2025 | 27 | 0 | 123.40M | $35.56B | n/a | −1 |
| Q2 2025 | 25 | +2 | 110.22M | $36.42B | +2 | n/a |
| Q1 2025 | 20 | +1 | 48.70M | $16.02B | +1 | n/a |
| Q4 2024 | 19 | -1 | 48.42M | $13.37B | n/a | −1 |
| Q3 2024 | 19 | -1 | 37.77M | $13.08B | n/a | −1 |
| Q2 2024 | 20 | n/a | 38.82M | $12.83B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 25.76M | +0.1% | $7.42B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 22.09M | -1.1% | $6.37B | 0.1% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 13.34M | n/a | $3.85B | 0.1% | n/c | 1 | SEC ↗ ×38 |
| 4 | State Street Global Advisors ✦ (passief) | 12.12M | -1.2% | $3.49B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 11.30M | +9.8% | $3.26B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 10.67M | -4.4% | $3.08B | 0.2% | ▼ Trim | 2 | SEC ↗ ×6 |
| 7 | Dodge & Cox ✦ | 9.31M | +4.0% | $2.68B | 1.4% | ▲ Add | 6 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 6.00M | +0.7% | $1.72B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 3.68M | n/a | $1.06B | 0.1% | n/c | 1 | SEC ↗ ×17 |
| 10 | Arrowstreet Capital ✦ | 2.70M | +7.5% | $777.01M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 11 | Capital World Investors ✦ | 1.33M | +2.9% | $383.18M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 1.29M | n/a | $371.42M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 13 | AQR Capital Management ✦ | 816.74K | -28.1% | $235.43M | 0.2% | ▼ Trim | 6 | SEC ↗ ×5 |
| 14 | Bridgewater Associates ✦ | 603.14K | -2.2% | $173.85M | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 427.14K | -22.4% | $123.12M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 393.94K | -59.0% | $113.55M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 385.85K | -68.8% | $111.22M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | Millennium Management ✦ | 255.08K | +102.3% | $73.53M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 213.76K | -7.2% | $61.62M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 20 | Glenview Capital ✦ | 187.76K | -49.5% | $54.12M | 1.3% | ▼ Trim | 6 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 173.60K | -25.0% | $50.04M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 22 | Greenlight Capital (DME Capital) ✦ | 93.75K | 0.0% | $27.02M | 1.1% | Held | 2 | SEC ↗ ×2 |
| 23 | Marshall Wace ✦ | 92.31K | -86.4% | $26.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 83.56K | +25.6% | $24.09M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 75.84K | +44.2% | $21.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 26 | GAMCO Investors ✦ | 13.39K | +0.4% | $3.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 1.23K | -55.1% | $354,990 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $1.11B | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,635 houders, 229.05M aandelen, $59.07B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 617 aand · $175,259
Officer · 2.68K aand · $748,516
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie